New York, USA
Joined December 2008
Replying to @FedExHelp
@FedExHelp I hate FedEx. Another botched delivery by fedex. I just received notification that no one was at my house. The funny thing is there wasn’t just one person, not two, not three, not four, but five people at my house, two of which were outside. @UPS is so much better.
4
47
The driver said no one was home. Not only was I home, but four other people were at my house.
1
21
He left the tag at 2:45. I contacted FedEx support at 2:45. Bob from the Philippines could have contacted the driver and told him to turn around, it would have saved another trip.
1
27
Avoid @TMobile at all costs. Their promotions are a scam and they will do EVERYTHING they can to screw you out of every possible dollar they can. I have never had an experience as horrible as I have with @TMobileHelp. #AvoidLikeThePlague
1
222
#Yankees Fire Brian Cashman Hit "like" and "retweet" if you approve.
38
363
9
1,124
@EL20228888 $450 is more realistic. It is possible there is. 20%-30% pop after the split because a more affordable price makes it attractive to more retailers, but that’s only if Cap’n Kenny, et al, decide they want to throw SHOP a bone.
Paul Zonis retweeted
$SAVA Amazing news FDA DOING THE RIGHT THING Now let the Clinical Trial Do it’s thing And hopefully help millions in need of treatment! #ENDALZ #HOPE @CassavaSciences @LuoshengPeng @lindsaybbar
11
40
4
138
@praddenkeefe the long article doesn’t mention Yale research (by Dr. Bordey’s neuroscience lab) testing @CassavaSciences’ Alzheimer’s drug and finding biological activity in the brain (preclinical research) for a different debilitating neuro disorder but via a similar mechanism
1
2
8
pubmed.ncbi.nlm.nih.gov/3207… please read this independent evaluation of cassava sciences’ drug as a potential treatment for another brain disease
1
2
6
$SAVA: a heavily manipulated stock w/ two promising candidates for early Alzheimer’s disease directions & treatments. Waiting for a thorough update from the company.
$SAVA - @NewYorker it would of been nice if you can release an article with actual facts and get things straight might help millions of people with the promising safe treatment #SIMUFILAM @Veganhippo21 @CassavaSciences @praddenkeefe @LuoshengPeng reddit.com/r/SAVA_stock/comm…
4
17
63
Paul Zonis retweeted
Replying to @praddenkeefe
@praddenkeefe failed to mention that JT actually hid the short position and misled the public as it was leaked (only disclosing the short position after they succeeded in manipulating the share price they had taken a bet against). $SAVA
2
16
4
46
Paul Zonis retweeted
Indeed SAD for patients but at the same time seemed to be extremely dangerous imo for the short term potential benefit , please support as there are other breakthrough from other companies targeting different and safe approach like $SAVA @CassavaSciences currently in P3 #ENDALZ
1
17
1
39
Family Testimonial to the Simufilam Trials with Hilary Metz Esq. Friday 9 am EST stream, watch and subscribe: youtu.be/7VcIYyeUey8 $SAVA
2
5
16
Alzheimer's disease is bipartisan, can affect anyone. The most amazing drug in phase 3 by Austin-based Cassava Sciences. Get FDA to fast track this!!! This should be bipartisan. Get it done! @amyklobuchar @tedcruz @RandPaul @GovAbbott @GovRonDeSantis $SAVA #Bullish In my opinion
2
6
10
ad-science.org is a blog that has never mentioned stock price or asked you to invest in sava. All it’s articles are fact based. In fact, for the most part we simply react to the falsifications perpetuated by shorts like you. Thank you for your time today Mr. Bagchi
1
4
11
Paul Zonis retweeted
$SAVA Dr. Douglas Baker shares his personal story about Cassava Sciences’ trial patients @LuoshengPeng @BestOfUsInvest @IBD_AGatlin @JoeSpringer @ADScience4 @alzassociation ad-science.org/2022/01/09/dr…
1
19
3
44
WE LOOK AT MOUNTING ANECDOTAL EVIDENCE OF SIMUFILAM We review Dr. Doug Baker's interview witnessing 2 patients in the P2 open label study. 9 am EST stream, watch and subscribe: youtu.be/b7mkn5Bn0p0 $SAVA
1
5
21
@ProfRobHoward, @adamfeuerstein, @statnews, @wsj, @davidamichaels, @joewalkerWSJ, @Drnotadr, @clicksandhisses, @LetsHaveABall2, @arkabagchi24, @LabatonSucharow, Jordan Thomas and David Bredt.
3
3
13